- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about REGN
Recent news which mentions REGN
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week
October 30, 2023
From Benzinga
Are Your Eyes At Grave Risk? FDA Issues Dangerous Warning Over Popular Drops From CVS, Target, Cardinal Health And More
October 28, 2023
From Benzinga
SNY Stock Sinks 15% as Sanofi Plans Consumer Unit Spinoff
October 27, 2023
From InvestorPlace
Stock-Split Watch: Could These 2 Growth Stocks Be Next?
October 25, 2023
From Motley Fool
Which Is the Better Long-Term Hold for Investors: Pfizer or Roche?
October 21, 2023
From Motley Fool
$100 Invested In This Stock 20 Years Ago Would Be Worth $6,000 Today
October 19, 2023
Tickers
REGN
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 18, 2023
From Benzinga
Cantor Fitzgerald Maintains Neutral Rating for Regeneron Pharmaceuticals: Here's What You Need To Know
October 16, 2023
Tickers
REGN
From Benzinga
2 Healthcare Stocks Near 52-Week Highs Still Worth Buying
October 16, 2023
From Motley Fool
Sanofi reaps rewards of immunology investment with eczema results
October 13, 2023
From MarketWatch
The Latest Analyst Ratings for Regeneron Pharmaceuticals
October 11, 2023
Tickers
REGN
From Benzinga
Down 45%, Is Intellia a Buy?
October 10, 2023
From Motley Fool
This Market-Beating Stock Just Gave Investors More Reasons to Invest
October 05, 2023
Tickers
REGN
From Motley Fool
From Motley Fool
$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today
October 04, 2023
Tickers
REGN
From Benzinga
MAIA Secures FDA Clearance Of IND Application For THIO For Non-Small Cell Lung Cancer
October 03, 2023
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 02, 2023
From Benzinga
Stock Split Watch: Is Regeneron Pharmaceuticals Next?
September 30, 2023
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
September 28, 2023
From Benzinga
Analyst Expectations for Regeneron Pharmaceuticals's Future
September 21, 2023
Tickers
REGN
From Benzinga
This Recent FDA Approval Could Give Regeneron's Top Line a Big Boost
September 20, 2023
Tickers
REGN
From Motley Fool
3 Stocks to Buy to Ride Europe’s Coming Market Surge
September 19, 2023
From InvestorPlace
$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today
September 18, 2023
Tickers
REGN
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 15, 2023
September 15, 2023
From Benzinga
Peering Into Regeneron Pharmaceuticals's Recent Short Interest
September 14, 2023
Tickers
REGN
From Benzinga
AI Integration In Biotech & Pharma: Companies Positioned To Benefit
September 11, 2023
From Benzinga
Morgan Stanley says it’s a lonely bull, recommending government bonds
September 11, 2023
From MarketWatch
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.